Announced Wed, 2 Sept · 08:55 IST
CARE reaffirms SMS Pharma ratings; outlook cut from Positive to Stable
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.8%1-day move
₹367.35
prior close
₹367.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3-0.0+0.7+1.3+1.8+7.2+8.2+8.4+11.5+26.9————
Up moveDown movePending
AI summary
CARE Ratings reaffirmed SMS Pharmaceuticals' bank facility ratings. Long-term facilities held at CARE A and short-term at CARE A1. Total rated limits were enhanced from Rs 350.87 crore to Rs 570.07 crore (long-term) plus Rs 52.83 crore (short-term), about Rs 622.90 crore overall. However, the outlook was revised from Positive to Stable, pointing to steady rather than improving credit profile.
Likely market impact
Rating held but outlook trimmed from Positive to Stable; higher borrowing limits support growth, but no near-term upgrade expected.